Blood | 2023
A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease
Magenau JM, Jaglowski S, Uberti J, Farag SS, Mansour Riwes M, Pawarode A, Anand S, Ghosh M, Maciejewski J, Braun TM, Devenport M, Lu S, Banerjee B, DaSilva C, Devine SM, Zhang MJ, Burns LJ, Liu Y, Zheng P, Reddy P
PubMed
PMID: 37647633
Abstract
Related Articles
CIBMTR Study #: CS20-04